Your browser doesn't support javascript.
loading
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Jenner, Matthew W; Pawlyn, Charlotte; Davies, Faith E; Menzies, Tom; Hockaday, Anna; Olivier, Catherine; Jones, John R; Karunanithi, Kamaraj; Lindsay, Jindriska; Kishore, Bhuvan; Cook, Gordon; Drayson, Mark T; Kaiser, Martin F; Owen, Roger G; Gregory, Walter; Cairns, David A; Morgan, Gareth J; Jackson, Graham H.
Afiliación
  • Jenner MW; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Pawlyn C; The Institute of Cancer Research, London, UK.
  • Davies FE; The Royal Marsden NHS Foundation Trust, London, UK.
  • Menzies T; Perlmutter Cancer Center, NYU Langone Health, New York, USA.
  • Hockaday A; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Olivier C; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Jones JR; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Karunanithi K; Eastbourne District General Hospital, Eastbourne, UK.
  • Lindsay J; Brighton and Sussex Medical School, University of Sussex, Sussex, UK.
  • Kishore B; Kings College Hospital NHS Foundation Trust, London, UK.
  • Cook G; University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
  • Drayson MT; East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.
  • Kaiser MF; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Owen RG; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Gregory W; Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Cairns DA; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Morgan GJ; The Institute of Cancer Research, London, UK.
  • Jackson GH; The Royal Marsden NHS Foundation Trust, London, UK.
Br J Haematol ; 201(2): 267-279, 2023 04.
Article en En | MEDLINE | ID: mdl-36541152
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido